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The human NatA protein N!-terminal-acetyltransferase complex is responsible for cotranslational N-
terminal acetylation of proteins with Ser, Ala, Thr, Gly, and Val N termini. The NatA complex is composed of
the catalytic subunit hNaa10p (hArd1) and the auxiliary subunit hNaa15p (hNat1/NATH). Using immuno-
precipitation coupled with mass spectrometry, we identified endogenous HYPK, a Huntingtin (Htt)-interacting
protein, as a novel stable interactor of NatA. HYPK has chaperone-like properties preventing Htt aggregation.
HYPK, hNaa10p, and hNaa15p were associated with polysome fractions, indicating a function of HYPK
associated with the NatA complex during protein translation. Knockdown of both hNAA10 and hNAA15
decreased HYPK protein levels, possibly indicating that NatA is required for the stability of HYPK. The
biological importance of HYPK was evident from HYPK-knockdown HeLa cells displaying apoptosis and cell
cycle arrest in the G0/G1 phase. Knockdown of HYPK or hNAA10 resulted in increased aggregation of an
Htt-enhanced green fluorescent protein (Htt-EGFP) fusion with expanded polyglutamine stretches, suggesting
that both HYPK and NatA prevent Htt aggregation. Furthermore, we demonstrated that HYPK is required for
N-terminal acetylation of the known in vivo NatA substrate protein PCNP. Taken together, the data indicate
that the physical interaction between HYPK and NatA seems to be of functional importance both for Htt
aggregation and for N-terminal acetylation.
N!-terminal acetylation is among the most common protein
modifications in eukaryotes, occurring on "50% of Saccharo-
myces cerevisiae proteins and"80% of human proteins (12). In
yeast, four types of N!-terminal acetyltransferases (NATs)
have been defined (NatA-NatD), while a fifth type, NatE, has
been hypothesized (21, 32–34, 38). For humans, NatA, NatB,
NatC, and NatE were recently presented (2, 4, 18, 39, 40). A
revised NAT-subunit nomenclature was recently introduced in
order to have identical names for orthologous subunits from
different species, and each gene was denoted NAA (N!-acetyl-
transferase) followed by a number depending on Nat type and
the type of subunit (catalytic/auxiliary) (32). The major human
NAT complex, hNatA, is composed of the catalytic subunit
hNaa10p (previously named hArd1) and the auxiliary subunit
hNaa15p (hNat1/NATH) (4). Human NatA is evolutionarily
conserved from the yeast complex in terms of subunit compo-
sition and substrate specificity (12, 26, 28). However, in con-
trast to yeast cells, human cells potentially contain several
distinct NatA complexes due to the presence of two genes for
each of the two NatA subunits, NAA10 and NAA15 (6, 8).
Protein N-terminal acetylation occurs on the ribosome when
the nascent polypeptide emerges (21, 29, 30, 41, 42). Proteins
with Ser, Thr, Gly, Ala, Val, or Cys N termini are potential
substrates of NatA (12), while NatB and NatC potentially
acetylate specific classes of substrates that still carry the initi-
ator Met (34). The biological importance of the human NatA
complex was evident from knockdown experiments where in-
duction of apoptosis and growth arrest of cells in the G1/G0
phase were the resulting phenotypes (9, 11, 20, 25). The phe-
notypes induced by hNatA depletion most likely reflect the fact
that one or more specific substrate proteins lack proper N!
acetylation, in view of the fact that a large quantitative pro-
teomic analysis of the acetylation status of protein N termini in
hNaa15p-hNaa10p knockdown cells revealed a decrease in the
level of N! acetylation of some partially acetylated substrates
compared to that in control cells (12).
To further characterize the human NatA complex, we
looked for the presence of stable interaction partners of
hNaa15p and hNaa10p. Here we present data identifying the
Huntingtin (Htt) yeast two-hybrid protein K (HYPK) as a
novel factor involved in cotranslational NatA acetylation.
HYPK, originally identified in a yeast two-hybrid screen during
a search for potential interaction partners for the Huntingtin
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N!-terminal acetylation, we immunoprecipitated the two NatA
subunits, hNaa15p and hNaa10p, using specific antibodies, and
analyzed the immunoprecipitated proteins by LC-MS/MS after
trypsin digestion. From four independent analyses of both anti-
hNaa15p and anti-hNaa10p, we considered only those proteins
identified in all eight setups analyzed by at least two distinct
peptides to be very likely specific candidate interaction pro-
teins of the hNaa15p-hNaa10p complex. By using these strin-
gent criteria, we identified only one novel putative interaction
partner, HYPK, in addition to the known NatA subunits
hNaa15p and hNaa10p (4) and the physical partner hNaa50p
(hNat5/hSan) (5). HYPK was not present in any of the four
negative controls using unspecific antibodies. An overview of
the identified HYPK-specific peptides is presented in Table S1
and Fig. S1a in the supplemental material. The MS/MS spec-
trum of one of these peptides, 54EIQSSNLETAMSVIGDR70,
is shown in Fig. S1b in the supplemental material. Further-
more, the hNatA-HYPK interaction was confirmed by several
assays, as described below.
Direct physical interaction between HYPK and hNaa15p.
To elucidate the direct physical interaction between HYPK
and the components of the hNatA complex, we performed
interaction studies using recombinant proteins produced in E.
coli. The results demonstrated that purified HYPK physically
binds to hNaa15p but not to hNaa10p or hNaa50p. Using
domains of the hNaa15p protein, we mapped the interaction to
amino acids 500 to 865 (Fig. 1A). This region contains a pre-
dicted coiled coil at amino acids 583 to 635. Also, HYPK is
predicted to have a coiled-coil region at amino acids 69 to 111
(Fig. 1B). Thus, it is possible that hNaa15p and HYPK asso-
ciate directly via a coiled-coil interaction. The human HYPK
protein contains 129 amino acids and has a predicted molec-
ular mass of 14.7 kDa and a pI of 4.9. Figure 1B schematically
shows the regions of the HYPK protein, including an acidic
region, a putative SH3 binding domain, and the predicted
coiled coil (from ELM [http://elm.eu.org/]). The hNaa15p pro-
tein, of 866 amino acids, is also outlined schematically, with
tetratricopeptide repeat (TPR) domains and a putative coiled-
coil region.
HYPK is a cytoplasmic protein associated with ribosomes.
To study the expression of the HYPK protein in human cells,
we generated a rabbit polyclonal antibody to HYPK, using a
HYPK-specific peptide. Western blotting of several human cell
lines demonstrated that the antibody recognized a protein of
the expected size of approximately 15 kDa (see Fig. S2a in the
supplemental material). Western blotting using anti-HYPK
with cell lysates overexpressing Xpress-HYPK or HYPK-V5
gave a strong signal at the expected size of "19 kDa, demon-
strating that the antibody recognizes the HYPK protein (see
Fig. S2b in the supplemental material). In order to study the
subcellular localization of HYPK, Xpress-HYPK was trans-
fected into HeLa cells. Immunofluorescence analysis revealed
that Xpress-HYPK localized mainly to the cytoplasm (Fig.
2A). Endogenous HYPK also localized primarily to the cyto-
plasm, although some staining was observed in the nucleus
(Fig. 2B). The cytoplasmic localization is in agreement with
a possible functional connection to the NatA complex. We
further isolated polysomes from HeLa cells and identified
HYPK in the polysomal fractions along with hNaa15p, in-
dicating that the protein is associated with ribosomes (Fig.
3). This observation suggests that the interaction between
HYPK and hNaa15p-hNaa10p may occur at the ribosome.
FIG. 1. The C terminus of hNaa15p interacts directly with HYPK. (A) Purified MBP-hNaa15p fusion proteins containing N-terminal MBP and
a His tag fused to a segment of the hNaa15p protein, as indicated, were purified and bound to Ni-affinity beads. HYPK was separately fully purified
and added to the beads containing different MBP-hNaa15p fusions. After incubation with rotation for 10 min and several washing steps, the
MBP-hNaa15p beads were analyzed for HYPK binding by SDS-PAGE and Western blotting using anti-HYPK. A positive signal indicates that
purified HYPK binds to the MBP-hNaa15p fusion protein. Equal amounts of the different MBP-hNaa15p fusions used were confirmed by
SDS-PAGE and Coomassie staining. (B) Schematic model of the predicted domains of hNaa15p and HYPK and the potential regions involved
in the hNaa15p-HYPK interaction. TPR, tetratricopeptide repeat.






Supplementary figure S1. HYPK identified in hNaa10p-hNaa15p immunoprecipitates. 
(A) The amino acid sequence of the HYPK protein is shown, with the identified tryptic 
peptides from anti-hNaa10p and anti-hNaa15p affinity extracts in bold and underlined. 
Based on the HYPK-specific peptides identified by MS/MS in our immunoprecipitation 
experiments, we are not able to distinguish between the three potential variants of HYPK. 
(B) MS/MS spectrum of the HYPK peptide 54EIQSSNLETAMSVIGDR70, identified in a 
hNaa10p affinity extraction. The peptide precursor ion current was 2.16 x 10 5. The 
fragments of the +2 peptide precursor ion fragments were identified by the program 
SEQUEST (16) as +1 individual b or y ions, which are labeled in the spectrum. Almost 
all major peaks are assigned; the peptide had an Xcorr of 4.58, and a probability of 
correct sequencing, based on a machine learning analysis of the mass spectrometry data 
and SEQUEST parameters (Anderson, D. C. et al.,  J.Proteome.Res. 2003  2:137-146) of 
99%. The mass assignments for the individual b and y ions are shown in the inset table, 
with the major matched ions indicated in bold. 
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 TABLE S1. Overview of HYPK peptides identified in hNaa10p-hNaa15p 
immunoprecipitatesa.   
HYPK peptides anti-hNaa15p extracts anti-hNaa10p extracts 
 peptide probability peptide probability 
92KEDLELIMTEMEISR106 0.99 0.98 
54EIQSSNLETAMSVIGDR70 - 0.99 
35KHDSGAADLER45 0.95 0.98 
93EDLELIMTEMEISR106 0.65 0.94 
92KEDLELIM#TEM#EISR106 0.50 0.93 
46VTDYAEEK53 0.92 0.86 
93EDLELIM#TEM#EISR106 0.85 - 
115EHM#GNVVEALIALTN129 0.84 0.54 
54EIQSSNLETAMSVIGDRR71 0.74 - 
54EIQSSNLETAM#SVIGDR70 0.61 0.57 
93EDLELIMTEM#EISR106 0.58 - 
46VTDYAEEKEIQSSNLETAM#SVIGDR70 0.52 - 
 
HYPK (gi|27734984) was identified in 4 of 4 hNaa10p and hNaa15p affinity 
extracts.  
aEach peptide was sequenced multiple times in a number of different 2D 
lc/ms/ms runs. The probabilities of correct peptide sequencing were derived 
from support vector machine learning calculations (Anderson, D. C. et al.,  





Supplementary figure S2. Test of anti-HYPK antibody. (A) Lysates of different human 
cell lines were applied to SDS-PAGE and Western blotting as indicated (see also 
materials and methods) using anti-HYPK and anti-β-tubulin. A band at ~15 kDa most 
likely representing HYPK is indicated. The asterisks indicate bands possibly representing 
unspecificity or perhaps slower migrating forms/complexes of HYPK. (B) HEK293 cells 
were transfected with plasmids pXpress-HYPK, pHYPK-V5 or no plasmid as indicated. 
After 48 hours cells were harvested and the resulting lysates processed by SDS-PAGE 
and Western blotting using anti-Xpress, anti-V5 and anti-HYPK. 
 
Since HYPK was coimmunoprecipitated with both anti-
hNaa15p and anti-hNaa10p, it is likely that HYPK interacts
directly or indirectly with both proteins simultaneously, and thus
HYPK is most likely associated with the hNaa15p-hNaa10p com-
plex. hNaa15p-hNaa10p cotranslationally acetylates the N termini
of nascent polypeptides, and the hNatA complex is associated
with ribosomes (4). If HYPK is a component of the hNaa15p-
hNaa10p complex per se and not just associated with ribosomes,
then HYPK should interact with hNaa15p and hNaa10p indepen-
dently of translation. We therefore analyzed the interaction be-
tween hNaa15p andHYPK proteins in HeLa cells after treatment
with cycloheximide, which inhibits translation (17). The amount
of hNaa15p-V5 protein coimmunoprecipitated by anti-Xpress-
HYPK was not significantly affected by the cycloheximide treat-
ment (Fig. 4). This indicates that even though the HYPK-hNatA
interaction may occur at the ribosome, active translation is not
obligatory for the interaction to occur. Thus, HYPK stably asso-
ciates with hNatA, and their common binding to the ribosomes
strongly indicates a common function during protein translation.
HYPK is a specific factor of the NatA complex. The human
hNaa15p-hNaa10p NatA complex is homologous to the yeast
NatA complex. In yeast and humans, there are three major
NAT complexes performing cotranslational N-terminal acety-
FIG. 2. Subcellular localization of HYPK. (A) (Left) HeLa cells were transfected with a plasmid encoding Xpress-HYPK, and at 48 h
posttransfection, cells were fixed and anti-Xpress antibodies and Alexa 488-conjugated anti-mouse antibodies were used to visualize Xpress-HYPK.
(Middle) DAPI (4!,6-diamidino-2-phenylindole) staining was used to visualize the nuclei of the cells. (Right) Overlay of DAPI and Xpress-HYPK
signals. More than 200 transfected cells were inspected, and representative cells are shown. (B) Twenty-four hours after being seeded, HeLa cells
were fixed and anti-HYPK and Alexa 488-conjugated anti-rabbit antibodies were used to visualize endogenous HYPK. Rabbit IgG was used as an
unspecific negative control. DAPI staining is presented next to each sample to visualize nuclei and verify the presence of cells. Pictures are
representative of three independent experiments in which at least 100 cells were taken into account.
FIG. 3. HYPK cosediments with polysomal fractions in a salt-sen-
sitive manner. Polysomal pellets from HeLa cells were resuspended in
buffer containing increasing concentrations of KCl. Cell lysate and
polysomal pellets after KCl treatment were analyzed by SDS-PAGE
and Western blotting. The membrane was incubated with anti-HYPK,
anti-hNaa15p, anti-L26 (ribosomal protein), and anti-CytC antibodies.
Molecular mass markers (in kDa) are indicated on the left. Results
shown are representative of three independent experiments.
FIG. 4. HYPK-hNaa15p interaction is independent of active trans-
lation. HEK293 cells were cotransfected with plasmids expressing
Xpress-HYPK and hNaa15p-V5. At 48 h posttransfection, cells were
treated with 50 "g/ml cycloheximide (CHX) or solvent (control) for 30
min. The cells were then harvested and subjected to immunoprecipi-
tation (IP), using anti-Xpress or negative-control antibodies. The pres-
ence of hNaa15-V5 in complex with Xpress-HYPK was analyzed by
SDS-PAGE and Western blotting, using anti-V5. The inhibitory effect
of CHX on protein translation was verified in parallel samples detect-
ing the reduction of unstable proteins. The results shown are repre-
sentative of three independent experiments.
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lation, namely, NatA, NatB, and NatC. The human homo-
logues of the large auxiliary subunits of the NatB and NatC
complexes, hNaa25p (hMDM20) and hNaa35p (hMAK10), re-
spectively, probably perform functions in the human NatB and
NatC complexes similar to that of the large auxiliary hNaa15p
subunit in the human NatA complex (39, 40). To investigate
if HYPK specifically interacts with the human NatA com-
plex or if it more generally contacts NAT complexes, we
tested the interaction between Xpress-HYPK and the
hNaa25p and hNaa35p proteins. Xpress-HYPK did not in-
teract with hNaa25p or hNaa35p-V5, in contrast to what was
observed for hNaa15p-V5 (Fig. 5). Thus, HYPK appears to be
a specific factor for the hNatA complex, not interacting with
the other two major human NATs, hNatB and hNatC.
HYPK knockdown results in cell death and accumulation of
cells in the G1/G0 phase. Different siRNAs were tested for the
ability to knock down HYPK expression. RT-PCR demon-
strated that 4 of 5 tested siRNAs significantly reduced the level
of HYPK mRNA in HeLa cells at 24 h posttransfection (Fig.
6A). The most efficient siRNAs, siHYPK-1, -2, -4, and -5, were
used as a mixed pool in subsequent experiments. RT-PCR
demonstrated efficient and specific knockdown of all three of
the NAA10, NAA15, and HYPK genes by gene-specific siRNAs
(Fig. 6B). Western blotting of cell lysates at 72 h post-siRNA
transfection, using anti-HYPK, demonstrated efficient knock-
down at the protein level (Fig. 6C). These results further
FIG. 5. HYPK interacts specifically with hNaa15p of hNatA, not
with hNaa25p of hNatB and hNaa35p of hNatC. HEK293 cells were
cotransfected with plasmids encoding Xpress-HYPK plus hNaa15p-
V5, hNaa25p-V5, hNaa35p-V5, or lacZ-V5, as indicated. At 48 h
posttransfection, cells were harvested and subjected to immunopre-
cipitation using anti-Xpress (anti-Xp) antibodies. The presence of
hNaa15p-V5, hNaa25p-V5, and hNaa35p-V5 in complex with Xpress-
HYPK was investigated by SDS-PAGE and Western blotting, using
anti-V5. (Top) Western blot of immunoprecipitates. (Bottom) West-
ern blot of cell lysates prior to immunoprecipitation. The results shown
are representative of three independent experiments.
FIG. 6. siRNA-mediated knockdown of HYPK, hNAA10, and
hNAA15. (A) Five individual siRNAs potentially targeting HYPK ex-
pression (H1 to H5) were tested by siRNA transfection of HeLa cells
and subsequent RT-PCR analysis at 48 h posttransfection, using prim-
ers specific for HYPK and !-actin. G, siGAPDH (negative control).
(B) siRNA-mediated knockdown in HeLa cells of the specific genes
HYPK, hNAA10, and hNAA15, as indicated. siLamin and siGAPDH
were used as negative controls. siHYPK is an equal mixture of the four
effective siHYPK siRNAs shown in panel A (H1, H2, H4, and H5; 50
nM total concentration). RT-PCR analysis was performed at 72 h
posttransfection. (C) SDS-PAGE and Western blotting, using anti-
HYPK, anti-hNaa10p, anti-hNaa15p, and antiactin, of HeLa samples
treated identically to those described for panel B. Protein levels were
quantified using a Fuji Film IR LAS 1000 documentation system and
Image Gauge 3.45. Protein levels in siLamin- and siGAPDH-treated
cells (the mean for these two negative controls) were set to 1.0, and
protein levels in sihNAA10-, sihNAA15-, and siHYPK-treated cells
were estimated relative to this and normalized to actin levels. HYPK
appeared as one or two specific bands, and the sum of the two was used
for quantification. All results are representative of at least three inde-
pendent experiments.
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the NAA10, NAA15, and HYPK genes by gene-specific siRNAs
(Fig. 6B). Western blotting of cell lysates at 72 h post-siRNA
transfection, using anti-HYPK, demonstrated efficient knock-
down at the protein level (Fig. 6C). These results further
FIG. 5. HYPK interacts specifically with hNaa15p of hNatA, not
with hNaa25p of hNatB and hNaa35p of hNatC. HEK293 cells were
cotransfected with plasmids encoding Xpress-HYPK plus hNaa15p-
V5, hNaa25p-V5, hNaa35p-V5, or lacZ-V5, as indicated. At 48 h
posttransfection, cells were harvested and subjected to immunopre-
cipitation using anti-Xpress (anti-Xp) antibodies. The presence of
hNaa15p-V5, hNaa25p-V5, and hNaa35p-V5 in complex with Xpress-
HYPK was investigated by SDS-PAGE and Western blotting, using
anti-V5. (Top) Western blot of immunoprecipitates. (Bottom) West-
ern blot of cell lysates prior to immunoprecipitation. The results shown
are representative of three independent experiments.
FIG. 6. siRNA-mediated knockdown of HYPK, hNAA10, and
hNAA15. (A) Five individual siRNAs potentially targeting HYPK ex-
pression (H1 to H5) were tested by siRNA transfection of HeLa cells
and subsequent RT-PCR analysis at 48 h posttransfection, using prim-
ers specific for HYPK and !-actin. G, siGAPDH (negative control).
(B) siRNA-mediated knockdown in HeLa cells of the specific genes
HYPK, hNAA10, and hNAA15, as indicated. siLamin and siGAPDH
were used as negative controls. siHYPK is an equal mixture of the four
effective siHYPK siRNAs shown in panel A (H1, H2, H4, and H5; 50
nM total concentration). RT-PCR analysis was performed at 72 h
posttransfection. (C) SDS-PAGE and Western blotting, using anti-
HYPK, anti-hNaa10p, anti-hNaa15p, and antiactin, of HeLa samples
treated identically to those described for panel B. Protein levels were
quantified using a Fuji Film IR LAS 1000 documentation system and
Image Gauge 3.45. Protein levels in siLamin- and siGAPDH-treated
cells (the mean for these two negative controls) were set to 1.0, and
protein levels in sihNAA10-, sihNAA15-, and siHYPK-treated cells
were estimated relative to this and normalized to actin levels. HYPK
appeared as one or two specific bands, and the sum of the two was used
for quantification. All results are representative of at least three inde-
pendent experiments.
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lation, namely, NatA, NatB, and NatC. The human homo-
logues of the large auxiliary subunits of the NatB and NatC
complexes, hNaa25p (hMDM20) and hNaa35p (hMAK10), re-
spectively, probably perform functions in the human NatB and
NatC complexes similar to that of the large auxiliary hNaa15p
subunit in the human NatA complex (39, 40). To investigate
if HYPK specifically interacts with the human NatA com-
plex or if it more generally contacts NAT complexes, we
tested the interaction between Xpress-HYPK and the
hNaa25p and hNaa35p proteins. Xpress-HYPK did not in-
teract with hNaa25p or hNaa35p-V5, in contrast to what was
observed for hNaa15p-V5 (Fig. 5). Thus, HYPK appears to be
a specific factor for the hNatA complex, not interacting with
the other two major human NATs, hNatB and hNatC.
HYPK knockdown results in cell death and accumulation of
cells in the G1/G0 phase. Different siRNAs were tested for the
ability to knock down HYPK expression. RT-PCR demon-
strated that 4 of 5 tested siRNAs significantly reduced the level
of HYPK mRNA in HeLa cells at 24 h posttransfection (Fig.
6A). The most efficient siRNAs, siHYPK-1, -2, -4, and -5, were
used as a mixed pool in subsequent experiments. RT-PCR
demonstrated efficient and specific knockdown of all three of
the NAA10, NAA15, and HYPK genes by gene-specific siRNAs
(Fig. 6B). Western blotting of cell lysates at 72 h post-siRNA
transfection, using anti-HYPK, demonstrated efficient knock-
down at the protein level (Fig. 6C). These results further
FIG. 5. HYPK interacts specifically with hNaa15p of hNatA, not
with hNaa25p of hNatB and hNaa35p of hNatC. HEK293 cells were
cotransfected with plasmids encoding Xpress-HYPK plus hNaa15p-
V5, hNaa25p-V5, hNaa35p-V5, or lacZ-V5, as indicated. At 48 h
posttransfection, cells were harvested and subjected to immunopre-
cipitation using anti-Xpress (anti-Xp) antibodies. The presence of
hNaa15p-V5, hNaa25p-V5, and hNaa35p-V5 in complex with Xpress-
HYPK was investigated by SDS-PAGE and Western blotting, using
anti-V5. (Top) Western blot of immunoprecipitates. (Bottom) West-
ern blot of cell lysates prior to immunoprecipitation. The results shown
are representative of three independent experiments.
FIG. 6. siRNA-mediated knockdown of HYPK, hNAA10, and
hNAA15. (A) Five individual siRNAs potentially targeting HYPK ex-
pression (H1 to H5) were tested by siRNA transfection of HeLa cells
and subsequent RT-PCR analysis at 48 h posttransfection, using prim-
ers specific for HYPK and !-actin. G, siGAPDH (negative control).
(B) siRNA-mediated knockdown in HeLa cells of the specific genes
HYPK, hNAA10, and hNAA15, as indicated. siLamin and siGAPDH
were used as negative controls. siHYPK is an equal mixture of the four
effective siHYPK siRNAs shown in panel A (H1, H2, H4, and H5; 50
nM total concentration). RT-PCR analysis was performed at 72 h
posttransfection. (C) SDS-PAGE and Western blotting, using anti-
HYPK, anti-hNaa10p, anti-hNaa15p, and antiactin, of HeLa samples
treated identically to those described for panel B. Protein levels were
quantified using a Fuji Film IR LAS 1000 documentation system and
Image Gauge 3.45. Protein levels in siLamin- and siGAPDH-treated
cells (the mean for these two negative controls) were set to 1.0, and
protein levels in sihNAA10-, sihNAA15-, and siHYPK-treated cells
were estimated relative to this and normalized to actin levels. HYPK
appeared as one or two specific bands, and the sum of the two was used
for quantification. All results are representative of at least three inde-
pendent experiments.
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lation, namely, NatA, NatB, and NatC. The human homo-
logues of the large auxiliary subunits of the NatB and NatC
complexes, hNaa25p (hMDM20) and hNaa35p (hMAK10), re-
spectively, probably perform functions in the human NatB and
NatC complexes similar to that of the large auxiliary hNaa15p
subunit in the human NatA complex (39, 40). To investigate
if HYPK specifically interacts with the human NatA com-
plex or if it more generally contacts NAT complexes, we
tested the interaction between Xpress-HYPK and the
hNaa25p and hNaa35p proteins. Xpress-HYPK did not in-
teract with hNaa25p or hNaa35p-V5, in contrast to what was
observed for hNaa15p-V5 (Fig. 5). Thus, HYPK appears to be
a specific factor for the hNatA complex, not interacting with
the other two major human NATs, hNatB and hNatC.
HYPK knockdown results in cell death and accumulation of
cells in the G1/G0 phase. Different siRNAs were tested for the
ability to knock down HYPK expression. RT-PCR demon-
strated that 4 of 5 tested siRNAs significantly reduced the level
of HYPK mRNA in HeLa cells at 24 h posttransfection (Fig.
6A). The most efficient siRNAs, siHYPK-1, -2, -4, and -5, were
used as mixed pool in subsequent experiments. RT-PCR
demonstrated efficient and specific knockdown of all three of
the NAA10, NAA15, and HYPK genes by gene-specific siRNAs
(Fig. 6B). Western blotting of cell lysates at 72 h post-siRNA
transfection, using anti-HYPK, demonstrated efficient knock-
down at the protein level (Fig. 6C). These results further
FIG. 5. HYPK interacts specifically with hNaa15p of hNatA, not
with hNaa25p of hNatB and hNaa35p of hNatC. HEK293 cells were
cotransfected with plasmids encoding Xpress-HYPK plus hNaa15p-
V5, hNaa25p-V5, hNaa35p-V5, or lacZ-V5, as indicated. At 48 h
posttransfection, cells were harvested and subjected to immunopre-
cipitation using anti-Xpress (anti-Xp) antibodies. The presence of
hNaa15p-V5, hNaa25p-V5, and hNaa35p-V5 in complex with Xpress-
HYPK was investigated by SDS-PAGE and Western blotting, using
anti-V5. (Top) Western blot of immunoprecipitates. (Bottom) West-
ern blot of cell lysates prior to immunoprecipitation. The results shown
are representative of three independent experiments.
FIG. 6. siRNA-mediated knockdown of HYPK, hNAA10, and
hNAA15. (A) Five individual siRNAs potentially targeting HYPK ex-
pression (H1 to H5) were tested by siRNA transfection of HeLa cells
and subsequent RT-PCR analysis at 48 h posttransfection, using prim-
ers specific for HYPK and !-actin. G, siGAPDH (negative control).
(B) siRNA-mediated knockdown in HeLa cells of the specific genes
HYPK, hNAA10, and hNAA15, as indicated. siLamin and siGAPDH
were used as negative controls. siHYPK is an equal mixture of the four
effective siHYPK siRNAs shown in panel A (H1, H2, H4, and H5; 50
nM total concentration). RT-PCR analysis was performed at 72 h
posttransfection. (C) SDS-PAGE and Western blotting, using anti-
HYPK, anti-hNaa10p, anti-hNaa15p, and antiactin, of HeLa samples
treated identically to those described for panel B. Protein levels were
quantified using a Fuji Film IR LAS 1000 documentation system and
Image Gauge 3.45. Protein levels in siLamin- and siGAPDH-treated
cells (the mean for these two negative controls) were set to 1.0, and
protein levels in sihNAA10-, sihNAA15-, and siHYPK-treated cells
were estimated relative to this and normalized to actin levels. HYPK
appeared as one or two specific bands, and the sum of the two was used
for quantification. All results are representative of at least three inde-
pendent experiments.
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proved that the !15-kDa band detected by Western blotting
using anti-HYPK was indeed HYPK.
HYPK knockdown did not significantly affect the levels of
hNaa15p and hNaa10p protein (Fig. 6C). In contrast, knock-
down of hNAA10 and hNAA15 appeared to reduce the level of
HYPK protein, in addition to a reduction of the proteins en-
coded by the respective target genes. As previously observed,
sihNAA15 also decreased the level of the hNaa10p protein (7).
In contrast to HYPK protein levels, levels of HYPK mRNA
were quite stable after sihNAA10 or sihNAA15 treatment. In
all setups analyzed, the pan-caspase inhibitor ZVAD-fmk was
added to the cells to avoid indirect effects of hNAA10 and
hNAA15 knockdown due to the induction of apoptosis (9),
further indicating that the observed reduction of HYPK pro-
tein might be due to destabilization of the HYPK protein.
RNAi-mediated knockdown of HYPK was performed to in-
vestigate the biological importance ofHYPK. Cells treated with
siRNAs targeting HYPK, hNAA10, hNAA15, or controls were
subjected to FACS cell cycle analysis at 72 h posttransfection
(Fig. 7). The data demonstrated that siHYPK-treated cells un-
derwent cell death, to a comparable extent (!22%) to that
observed for knockdown of hNAA10 or hNAA15 (!25%). Ad-
dition of the pan-caspase inhibitor ZVAD-fmk inhibited cell
death, indicating that it was caspase dependent. Furthermore,
there was an accumulation of cells in the G1/G0 phase after
siHYPK treatment, similar to that observed for sihNAA10 and
sihNAA15 treatment. Similar effects were also observed when
individual siRNAs targeting HYPK, siHYPK-1, and siHYPK-2
were used, demonstrating the specificity of the observed effects
(data not shown). In conclusion, knockdown of both HYPK
and hNatA induces cell death in HeLa cells, potentially via a
common function.
Knockdown ofHYPK and hNAA10 increases Huntingtin Q72
and Q103 aggregation. To investigate the possible functional
relationship between HYPK and the hNatA complex, we
wanted to test whether the hNatA complex is required for the
function of HYPK relating to Htt aggregation. HYPK was
previously shown to exhibit chaperone-like activity, interacting
with the N terminus of Htt, and overexpression of HYPK
reduced Htt polyQ aggregation and toxicity in Neuro2A cells
(36). In this study, we wanted to investigate endogenous
HYPK in relation to Htt polyQ. Knockdown of HYPK signif-
icantly increased the level of aggregation of HttQ72-EGFP and
HttQ103-EGFP compared to that in control HeLa cells (Fig.
8). This indicates that endogenous HYPK reduces polyQ-
mediated protein aggregation in nonneuronal cells. Further-
more, since HYPK physically interacts with the hNatA com-
plex and both hNaa10p and hNaa15p are required for the
stability of the HYPK protein, we analyzed the effects of
hNAA10 knockdown on Htt polyQ aggregation. Indeed, hNAA10
knockdown also increased the number of cells with HttQ72-
EGFP and HttQ103-EGFP aggregates (Fig. 8). We were not able
to detect any aggregates of HttQ25-EGFP, even when knocking
down HYPK and hNAA10. In order to elucidate the importance
of a native N terminus in this process, since this potentially will be
exposed to hNatA and HYPK during translation, we used an-
other set of plasmids expressing Htt polyQ with an N-terminal
EGFP tag: EGFP-HttQ23 and EGFP-HttQ74. Interestingly,
even though EGFP-HttQ74 demonstrated a significant number
of aggregates in control cells, HYPK or hNAA10 knockdown did
not increase the number of cells with EGFP-HttQ74 aggregates
(Fig. 8). To visualize HYPK and the NatA complex in cells ex-
pressing different Htt proteins and to determine whether HYPK
and/or hNatA associates with Htt aggregates, we performed im-
munofluorescence colocalization experiments. Aggregates with
different appearances were observed for the Htt proteins with
long polyQ stretches (Q72, Q74, and Q103), while a general and
diffuse staining was observable for HttQ23 and HttQ25 (Fig. 9).
Importantly, we were not able to detect significant colocalization
between any of the Htt proteins and HYPK or hNaa15p. Both
HYPK and hNatA prevent Htt polyQ aggregation, most likely by
contacting and/or acetylating the nascent Htt polyQ N-terminal
polypeptide during translation.
Knockdown of HYPK decreases N!-terminal acetylation of a
known NatA substrate. To further elucidate the functional
importance of the HYPK-hNaa15p-hNaa10p interaction, we
tested whether HYPK was important for NatA-mediated acet-
ylation. Recently, the first in vivo hNatA substrates were iden-
tified. Upon siRNA-mediated knockdown of hNAA10 and
hNAA15 in HeLa cells, we observed a partial but significant
reduction in N-terminal acetylation for a subset of suboptimal
hNatA substrates (12). We therefore cloned one of the genes
encoding an sihNatA-regulated substrate protein, namely,
PCNP, and coexpressed this protein while simultaneously
knocking down HYPK or hNAA10. After PCNP isolation and
SDS-PAGE-based separation, in-gel stable isotope labeling was
performed by in vitro trideutero acetylation. The extent of PCNP
FIG. 7. HYPK knockdown induces cell death and G1/G0 cell cycle
arrest. Flow cytometric cell cycle analysis of HYPK, hNAA10, and
hNAA15 knockdown cells was performed at 72 h posttransfection.
siLamin- and siGAPDH-treated samples were used as negative con-
trols. (Top panels) No ZVAD treatment. (Bottom panels) ZVAD
treatment to inhibit caspase activity and, thereby, induction of caspase-
mediated cell death. Experiments were performed three times, and
representative values are given.
1904 ARNESEN ET AL. MOL. CELL. BIOL.
N! acetylation was assessed following trypsinization and mass
spectrometric analysis of the N-terminal peptide 2ADGKAGDE
KPEKSQR16. The sihNAA10 sample confirmed the hNatA sub-
strate dependency of PCNP, and interestingly, PCNP was also
found to be less acetylated in the siHYPK sample (Fig. 10). This
demonstrated that HYPK is important, directly or indirectly, for
the N!-terminal acetylation of PCNP. A contaminating protein,
the 40S ribosomal protein S3, with the N terminus 2AVQISK
KR9, was picked up in all three samples. Interestingly, the N-
terminal-acetylation status of S3 was unaffected by sihNAA10 and
siHYPK treatment, in further agreement with our previous large-
scale analysis of hNatA knockdown cells (12). Thus, most likely,
only the hNatA substrates sensitive to hNatA knockdown are also
sensitive to HYPK knockdown in terms of a reduced N-terminal-
acetylation pattern. Furthermore, we analyzed the in vitro capac-
ity of the NatA complex immunoprecipitated from control or
HYPK knockdown cells to N-terminally acetylate a known sub-
strate peptide. Indeed, the capacity of NatA to acetylate a Ser-
starting peptide (SESS) diminished when HYPK levels were re-
duced (Fig. 11). The N terminus of the SESS peptide is derived
from a protein found to be acetylated fully in HeLa cells unaf-
fected by sihNatA knockdown (12). In summary, HYPK is re-
quired for optimal hNatA N-terminal-acetylation activity.
DISCUSSION
The functional characterization of the NatA N!-terminal
acetyltransferase revealed that two components, Naa10p
(Ard1p) and Naa15p (Nat1p), are required for catalytic activity
(26). These two partners interact in a physical complex (28),
and the complex is associated with ribosomes (21). The large
auxiliary subunit Naa15p mediates contact between the ribo-
some and nascent polypeptide and the catalytic subunit
Naa10p (21). The system appears to be conserved in humans,
where hNaa10p and hNaa15p interact with each other and with
ribosomes to perform N-terminal acetylation in vitro (4). Re-
cent functional studies demonstrated that expression of
hNaa10p and hNaa15p can complement a yeast strain lacking
yeast NatA by rescuing NatA-deletion phenotypes. Further-
more, when expressed in yeast, hNaa10p and hNaa15p could
N-terminally acetylate the same set of substrates as the yeast
NatA complex in vivo (12). A third subunit, Naa50p (Nat5p),
physically associated with NatA but was not required for NatA
activity, suggesting a distinct function (21).
There are several ribosome-associated protein biogenesis
factors (RPBs) potentially associated with nascent polypep-
tides. In yeast, these include the chaperones Ssb1 and Ssb2 and
the ribosome-associated complex (RAC), the nascent polypep-
tide-associated complex (NAC), the signal recognition particle
(SRP), methionine aminopeptidases (MAPs), and N!-terminal
acetyltransferase (NATs). A quantitative analysis of the differ-
ent RPBs relative to the number of ribosomes per cell indi-
cated a dynamic association between RPBs and ribosomes and
also suggested an ordered interplay between the RPBs (35).
However, direct interactions between NATs and other RPBs
have not been investigated. In the identification of the mam-
malian RAC, HYPK was copurified with RAC and the NatA
complex, but without any further distinction between the two
(27). Our current data strongly suggest that in human cells,
HYPK and the NatA complex cooperate at the ribosome.
FIG. 8. HYPK and hNAA10 knockdown increases Huntingtin aggregation. HeLa cells were transfected with the indicated siRNAs, and at 24 h
posttransfection, the medium was replaced and the cells were transfected with plasmids encoding the indicated Htt-EGFP fusion proteins.
Twenty-four hours after plasmid transfection, the cells were fixed, cells displaying Htt-EGFP aggregates were counted, and the percentage of cells
with aggregates among the transfected cells was calculated. At least 200 transfected cells were counted per sample, and values presented are
means " standard deviations (SD) for three to six independent experiments. P values for independent t tests for samples versus control are
indicated with asterisks (P # 0.05).
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FIG. 9. HYPK and hNaa15p do not colocalize with Htt aggregates. HeLa cells expressing various EGFP-tagged polyQ versions (left column)
were incubated with HYPK- or hNaa15p-specific antibodies, as indicated in the figure (second column from left). Alexa 594-conjugated anti-mouse
antibodies were used to visualize HYPK and hNaa15p. The third column from left presents an overlay of polyQ-EGFP and HYPK or hNaa15p.
DAPI staining was used to visualize DNA, as included in the overlay shown in the right column. Images were processed by deconvolution (Leica
4000 software). Bar, 25 !m.
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HYPK is required for efficient N-terminal acetylation of
known NatA substrates in vivo and in vitro (Fig. 10 and 11), and
NatA is required for HYPK stability and Htt polyQ aggrega-
tion (Fig. 6 and 8). The similar knockdown phenotypes also
suggest similar functional roles for HYPK and NatA (Fig. 7),
but at present it is not known whether these phenotypes are
caused by lack of N-terminal acetylation of specific substrates,
misfolding/aggregation of endogenous proteins, or both. If in-
deed HYPK is absolutely required for hNatA-mediated acet-
ylation in general, it should be defined as a subunit of the NatA
complex per se. However, a large-scale N-terminal-acetylation
analysis of HYPK knockdown cells or something similar
should be performed before such conclusions can be drawn.
The lack of HYPK in yeast suggests the presence of efficient
NatA activity independent of HYPK, and also, HYPK expres-
sion in yeast was not required for effective in vivo acetylation of
yeast NatA substrates by hNaa10p and hNaa15p (12). How-
ever, it should be noted that the degree of NatA-mediated
N-terminal acetylation is significantly higher in human cells
than in yeast cells and that the underlying cause(s) for this
difference has not yet been revealed (12). A human-specific
factor like HYPK, a factor increasing the efficiency of NatA-
mediated N-terminal acetylation, might contribute to this phe-
nomenon.
The S. cerevisiae protein most similar to HYPK is NACA. It
is interesting that the heterodimeric NAC, consisting of NACA
and NACB, is the first to contact nascent polypeptides as they
emerge from the ribosome (44), thus potentially placing the
NAC and NatA complexes in close proximity. A phylogenetic
analysis of HYPK and NACA is presented in Fig. S3 in the
supplemental material. Given the similarity between NACA
and HYPK and the association of HYPK with ribosomes and
hNaa15p-hNaa10p, it is tempting to speculate that HYPK also
contacts nascent polypeptides. HYPK then may mediate effec-
tive contact between the peptide and hNatA and/or act as a
chaperone preventing nascent polypeptide misfolding in order
for effective acetylation to occur. In human cells, HYPK and
NACA coexist, and it would be interesting to define whether
NACA and/or the NAC also directly contacts the NatA com-
plex at the ribosome and might be involved functionally in
N-terminal acetylation of certain substrates.
An interesting aspect relates to whether the effect of HYPK
FIG. 10. HYPK knockdown reduces NatA-mediated N-terminal acetylation. HeLa cells were transfected with siRNAs targeting hNAA10,
HYPK, or a control. At 24 h posttransfection, the medium was replaced and cells transfected with pPCNP-V5 plasmid. Forty-eight hours after
plasmid transfection, the cells were harvested and lysed, and PCNP-V5 was immunoprecipitated and processed as described in Materials and
Methods. ZVAD was added every 24 h to prevent induction of apoptosis. MS spectra of doubly charged peptide ions originating from the N
terminus of PCNP (GenBank accession no. Q8WW12) are shown. The peptide was identified as 2-ADGKAGDEKPEKSQR-16. The extent of
PCNP N! acetylation, as determined by an MS isotope pattern calculator (http://prospector.ucsf.edu), was calculated as being 97%, 73%, and 90%
in the control, sihNAA10, and siHYPK samples, respectively. The ellipsoids indicate the relative increases of the in vivo unacetylated N terminus
of PCNP in the sihNAA10- and siHYPK-treated samples compared to that in the control sample. The data are representative of two independent
experiments.
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and hNatA on Htt polyQ aggregation is mediated via a co-
translational process. There are indications that this might be
the case. First, both HYPK and hNatA are associated with
ribosomes. Second, an N-terminal EGFP tag (EGFP-HttQ74)
masking the N terminus of Htt polyQ from HYPK and hNatA
on the ribosome abrogated the effects of siHYPK and
sihNAA10 treatment on aggregation (Fig. 9). This suggests that
hNatA and HYPK must be in contact with the natural N
terminus of Htt at the ribosome in order to prevent Htt ag-
gregation. Third, we did not detect any significant colocaliza-
tion between Htt aggregates and HYPK/hNaa15p (Fig. 10),
which might be expected if hNatA-HYPK acted posttransla-
tionally on the aggregates. Thus, the reported interaction be-
tween HYPK and Htt (19, 36) is probably dynamic and per-
haps confined to Htt during translation and shortly after,
before aggregation occurs in the case of long stretches of
polyQ. Finally, it should be mentioned that the N terminus of
Htt is (Met)-Ala-Thr-Leu, making this a likely hNatA sub-
strate (12). Very recently, it was indeed demonstrated that Htt
is N-terminally acetylated, and given the fact that the N-ter-
minal 17 amino acid residues are critical for Htt aggregation
and subcellular localization (1), it is possible that this acetyla-
tion may directly affect Htt behavior. hNatA is the natural
candidate enzyme for the acetylation of the Ala N terminus of
Htt, and future experiments might reveal whether there is a
direct link between hNatA-mediated N-terminal acetylation of
Htt and Htt aggregation.
In conclusion, HYPK is a novel potential RPB directly and
functionally coupled to hNatA-mediated N-terminal acetyla-
tion and also with an important role in the prevention of
protein aggregation.
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FIG. 11. hNatA immunoprecipitated from HYPK knockdown cells
displays reduced in vitro acetylation activity. HeLa cells (approximately
5 ! 106 per sample) were transfected with the indicated siRNAs, and
at 24 h posttransfection, ZVAD was added to prevent induction of
apoptosis. After 48 h, the cells were harvested and lysed, and the lysate
was subjected to immunoprecipitation (IP) using an anti-hNaa15p
specific antibody. The beads containing functional hNatA complexes
were analyzed for N"-acetyltransferase activity, using [14C]acetyl-CoA
and a Ser-Asp-Ser-Ser (SESS)-starting 24-mer peptide known to be
acetylated by NatA in vitro. The amount of acetyl incorporation was
determined by isolation of the peptides followed by scintillation count-
ing. Verification of knockdown and the presence of equal levels of
hNaa15p in the immunoprecipitates were routinely confirmed. Exper-
iments were performed three times, and values are means # SD. P
values for independent t tests for siHYPK samples versus control are
indicated with an asterisk (P $ 0.05).
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Supplementary figure S3. Evolutionary origin of HYPK. The ancestor of HYPK/NACA 
probably duplicated sometime after the fungi and metazoa separated, since metazoa have 
both HYPK and NACA, but yeast only has NACA. C. elegans only seem to have NACA, 
in contrast to fruitfly and mosquito, which have both genes. Phylognetic tree of sequences 
from Ensembl families (see methods), with transcripts identified by species names and 
Ensembl transcript identifiers and rooted in a way that maximises the separation between 
the families. All genes below the named branch are from the named family, except where 
noted. The branch support values indicate some overlap between the groups, which is 
natural from an automatic definition (as used by Ensembl) of families that are related. 
The two branches marked with a circle have support values >= 0.75 and more confidently 
indicate the split between HYPK and NACA. Tree drawn with iTOL (Letunic I and 
Borch P, Bioinformatics, 2007 23:127-8). 

